Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension.
- Resource Type
- Article
- Source
- Cell Discovery; 12/22/2020, Vol. 6 Issue 1, p1-12, 12p
- Subject
COVID-19 CALCIUM antagonists AMLODIPINE HYPERTENSION ANTIHYPERTENSIVE agents SARS-CoV-2 - Language
- ISSN
- 20565968